Stocks
Chembio Diagnostics, Inc.CEMI
NASDAQHealthcareBiotechnology$0.46+0.22%
Specializing in rapid diagnostic tests, this company focuses on infectious diseases including HIV, hepatitis, and tropical diseases. Its point-of-care testing solutions are used in clinical labs and emergency settings, making it relevant for investors tracking pandemic preparedness stocks.
Market Cap: $16.7M52W Range: $0.19 – $1.24
Congressional Interest in Chembio Diagnostics, Inc. (CEMI)
1 member of Congress has disclosed 2 trades in Chembio Diagnostics, Inc. (CEMI), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
0
Sells
2
Who in Congress Is Trading CEMI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-24 | Tom Malinowski | sell | $1K – $15K |
| 2020-03-19 | Tom Malinowski | sell | $1K – $15K |